Davis R A, Kern F, Showalter R, Sutherland E, Sinensky M, Simon F R
Proc Natl Acad Sci U S A. 1978 Sep;75(9):4130-4. doi: 10.1073/pnas.75.9.4130.
Administration of the synthetic estrogen ethinyl estradiol (17alpha-ethinyl-1,3,5-estratriene-3,17beta-diol) decreases hepatic Na(+),K(+)-ATPase (ATP phosphohydrolase; EC 3.6.1.3) activity and bile flow to 50% and alters the composition and structure of surface membrane lipid in rats. Although the content of phospholipids was not changed by treatment, free cholesterol (130%) and cholesterol esters (400%) were increased in liver surface membrane fractions. These observations correlate with changes in membrane viscosity, as shown by electron spin resonance probes. Both rotational correlation time, using the isotropic probe methyl (12-nitroxyl)stearate, and the order parameter, determined by the anisotropic probe 5-nitroxylstearic acid, were significantly increased in liver surface membrane fractions from rats treated with ethinyl estradiol. Administration of Triton WR-1339, a nonionic detergent that corrects hepatic and serum lipid changes caused by ethinyl estradiol treatment, restored toward normal elevated membrane lipids and viscosity as well as Na(+),K(+)-ATPase activity and bile flow. Although restoration of normal liver surface membrane structure and function may be due to reversal of abnormal lipid composition, detergents also may directly alter membrane enzyme activity. Addition of Triton WR-1339 in vitro increased Na(+),K(+)-ATPase activity and reduced membrane viscosity of surface membranes from rats treated with ethinyl estradiol. Triton had no effect on either parameter in normal membrane preparations. Studies of membrane structure and function both in vivo and in vitro suggest that alterations in lipid composition may alter Na(+),K(+)-ATPase function and bile flow.
给予合成雌激素乙炔雌二醇(17α-乙炔基-1,3,5-雌甾三烯-3,17β-二醇)可使大鼠肝脏的钠钾ATP酶(ATP磷酸水解酶;EC 3.6.1.3)活性和胆汁流量降低至50%,并改变肝细胞膜表面脂质的组成和结构。虽然磷脂含量未因治疗而改变,但肝细胞膜表面组分中的游离胆固醇(增加130%)和胆固醇酯(增加400%)有所增加。如电子自旋共振探针所示,这些观察结果与膜粘度的变化相关。使用各向同性探针甲基(12-硝基氧基)硬脂酸测得的旋转相关时间以及使用各向异性探针5-硝基氧基硬脂酸确定的序参数,在接受乙炔雌二醇治疗的大鼠肝细胞膜表面组分中均显著增加。给予曲拉通WR-1339(一种可纠正乙炔雌二醇治疗引起的肝脏和血清脂质变化的非离子去污剂)可使升高的膜脂质和粘度以及钠钾ATP酶活性和胆汁流量恢复正常。虽然肝细胞膜表面结构和功能恢复正常可能是由于异常脂质组成的逆转,但去污剂也可能直接改变膜酶活性。在体外添加曲拉通WR-1339可增加接受乙炔雌二醇治疗的大鼠肝细胞膜表面的钠钾ATP酶活性并降低膜粘度。曲拉通对正常膜制剂中的这两个参数均无影响。体内和体外的膜结构与功能研究表明,脂质组成的改变可能会改变钠钾ATP酶的功能和胆汁流量。